Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | MAOA | P21397 | 2/20 | 0.43 |
| ▸ | MAOB | P27338 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | KIF11 | P52732 | 6/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL635988 | 1.00 | SLC6A4 (0.47) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL2837925 | 0.86 | SLC6A4 (0.46) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL162234 | 0.86 | SLC6A4 (0.46) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL636461 | 0.86 | SLC6A4 (0.46) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL30664386 | 0.84 | SLC6A4 (0.44) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL637387 | 0.80 | SLC6A4 (0.44) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL10038034 | 0.80 | ACHE (0.52) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL16329073 | 0.80 | ACHE (0.52) | SLC6A4CA12CA1CA2CA7 | |
| SCHEMBL1467139 | 0.79 | ALDH1A1 (0.46) | SLC6A4ALDH1A1CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL9722972 | 0.79 | LTA4H (0.45) | CA1CA2CA9MAOAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9079931-B2 | Ruthenium complex and method for preparing optically active alcohol compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| EP-2563799-B1 | RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND | TAKASAGO PERFUMERY CO LTD (JP) | 2015-02-11 | — | — | EP | disclosed |
| US-20130041151-A1 | RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-02-14 | — | — | US | disclosed |
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130041151-A1 | RUTHENIUM COMPLEX AND METHOD FOR PREPARING OPTICALLY ACTIVE ALCOHOL COMPOUND | ADH5, ADH1C, ADH1A | SLC6A4 3987/4885CA12 2846/4885CA1 2773/4885 |
| US-20070010695-A1 | Diphosphines, preparation and uses thereof | MPI, ITPA, DCPS | SLC6A4 4470/4885CA12 3105/4885CA1 3712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.